06.02.2019
- German and British drugmakers Merck KGaA and Glaxo SmoithKline have entered a global strategic alliance to jointly develop and commercialize M7824 (bintrafusp alfa), the German...
04.12.2018
- German pharmaceuticals, chemicals and laboratory products group Merck completed the sale of its Consumer Health business to US consumer products group Procter & Gamble (P&G) on Dec...
01.11.2018
- Merck KGaA, the German pharmaceuticals, chemicals and laboratory science group, is selling its MilliporeSigma Flow Cytometry unit to Luminex, based at Austin, Texas, in the US. The...
31.08.2018
- The European Commission has approved the sale by Merck KGaA of its global consumer health business to Procter & Gamble (P&G). The regulator said it had no competition concerns...
16.08.2018
- The Australian Patent Office has granted an application by Germany’s Merck KGaA to patent the use of paired CRISPR nickases. The Darmstadt-based group said, these “represent a...
01.08.2018
- The US Food and Drug Administration has accepted the resubmission of Merck KGaA’s New Drug Application (NDA) for cladribine tablets as a potential treatment for patients with...
07.06.2018
- German pharmaceuticals and chemicals life sciences group Merck KGaA has opened a BioReliance End-to-End Biodevelopment Center in Burlington, Massachusetts. The center is one of...
22.05.2018
- With a record number of more than 640 attendees and 80 speakers, this year’s Europe Annual Conference of the International Society for Pharmaceutical Engineering was the largest...
